Clinique Pep-Start™ Eye Cream

Clinique Pep-Start™ Eye Cream

Brand:
CLINIQUE
Manufacturer:
The Estée Lauder Companies, Inc.
Country of Origin:
USA
31 votes
Repurchase Rate0%

Quality

Joy

Value for money

Price segment

Description

Lightweight, refreshing eye cream hydrates, brightens. Perks up your look. Delivers a rush of hydration and instant brightening. Its cool touch and de-puffing tip help tired, puffy eyes look wide-awake, refreshed. Over time, a peptide cocktail helps skin stay smooth, hold hydration, become more resilient. Oil-free formula works under and over makeup. Use twice a day, morning and night. Pop ball tip up with thumb. Gently squeeze a small amount of product onto applicator tip. Swipe in circular motion around eye area, including lids. Use finger to smooth in any excess until absorbed. Reapply as needed throughout the day. Our Clinique Clean Philosophy No parabens. No phthalates. No fragrance. Just happy skin.

Ingredients

WATER, GLYCERIN, BUTYLENE GLYCOL, SQUALANE, CETYL ESTERS, DIMETHICONE, METHYL GLUCETH-20, POLYETHYLENE, GLYCERETH-26, POLYBUTENE, SUCROSE, MAGNOLIA OFFICINALIS BARK EXTRACT, SIGESBECKIA ORIENTALIS (ST. PAUL'S WORT) EXTRACT, ALGAE EXTRACT, MOLASSES EXTRACT/SACCHARUM OFFICINARUM/EXTRAIT DE MELASSE, SAPINDUS MUKUROSSI FRUIT EXTRACT, PALMITOYL TETRAPEPTIDE-7, WHEY PROTEIN/LACTIS PROTEIN/PROTEINE DU PETIT-LAIT, PALMITOYL HEXAPEPTIDE-12, TRIFLUOROACETYL TRIPEPTIDE-2, CAFFEINE, PHYTOSPHINGOSINE, ACETYL HEXAPEPTIDE-8, PALMITOYL TRIPEPTIDE-1, GLYCINE SOJA (SOYBEAN) PROTEIN, CAESALPINIA SPINOSA GUM, ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER, GLYCERYL POLYMETHACRYLATE, SUCROSE STEARATE, CAPRYLYL GLYCOL, PEG-8, SODIUM HYALURONATE, SIMETHICONE, POLYSORBATE 20, CARBOMER, SODIUM HYDROXIDE, DEXTRAN, HEXYLENE GLYCOL, SODIUM CITRATE, PHENOXYETHANOL, MICA, TITANIUM DIOXIDE (CI 77891), YEAST EXTRACT, BUTYROSPERMUM PARKII BUTTER

***

Ingredients are subject to change at the manufacturer's discretion. For the most complete and up-to-date list of ingredients, refer to the product packaging.

Comments 0